Breaks Categories: News

TuesdayApr 16, 2024 1:31 pm

CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

Continue Reading

ThursdayApr 11, 2024 11:16 am

CBDNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Announce Acquisition, Strengthen Position as ‘Powerhouse’ in Entertainment Space

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, and its wholly owned subsidiary, Lavish Entertainment, have closed on the full acquisition of ABI Create, a premier event-management and production company. ABI Create was founded in 2015 by Lavish Entertainment president and COO Marco Antonio Moreno. Since its inception, ABI Create has established a reputation for delivering high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions. The company has partnered with the NFL Super Bowl, San Diego and New York Comic Con events, EDC and Camp EDC, Bonnaroo Music Festival, the Waste Management…

Continue Reading

TuesdayApr 02, 2024 3:55 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives New Epilepsy, Anti-Viral Agent Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received three new patent awards. According to the announcement, the company was awarded two new patents in its epilepsy patent family; both awards were granted in the United States. The U.S. patents, which cover both swallowed capsules and dissolvable oral tablets, complement research indicating DehydraTECH-CBD has potential to decrease epileptic seizures in rodents and to be absorbed into the bloodstream more effectively than the current treatments. In addition, Lexaria was awarded a patent in Japan in is antiviral agent patent family. The new patents bring the total of…

Continue Reading

WednesdayMar 27, 2024 3:00 pm

CBDNewsBreaks – Software Effective Solutions Corp. (SFWJ) Marks Significant Progress Across Its Diverse Portfolio

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a leading entity in the cannabis and agricultural technology sectors, today announced remarkable advancements across its operations. MedCana is poised for significant growth and profitability with its subsidiaries in the final stages of negotiations to determine varietals to export to Europe and Australia, and Eko2o S.A.S. rapidly expanding its reach within the agricultural industry. MedCana’s strategic foray into cannabis production is nearing fruition, with operations gearing up to meet the stringent quality and regulatory standards of the European and Australian markets. In addition, Eko2o S.A.S., a majority-controlled subsidiary of MedCana, is making notable…

Continue Reading

TuesdayMar 26, 2024 11:27 am

CBDNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Renewed Partnership with IBN for Corporate Communication Support

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, is partnering with IBN, a financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. IBN and GTVN have previously worked together in 2021, and IBN’s renewed involvement “signifies a paramount advancement toward its objective of maximizing shareholder value and adeptly conveying [GTVH’s] narrative and strategic initiatives.” IBN will generate greater awareness for Golden Triangle Ventures by fully utilizing its investor-based distribution network of more than 5,000 syndication outlets along with various newsletters, social media channels, wire services, blogs and other outreach tools. “As we embark on…

Continue Reading

WednesdayFeb 14, 2024 2:54 pm

CBDNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ), Subsidiary Ink Multiyear Deal with Danziger Colombia

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) and its majority-controlled subsidiary, Eko2o Environmental Solutions S.A.S., have signed a multiyear contract with Danziger Colombia. According to the announcement, the agreement outlines plans for Colombia-based Eko2o, a leading provider of greenhouse infrastructure and agricultural technology, to provide greenhouse infrastructure services, irrigation products and technology to Danziger’s flower operations in Colombia. The company anticipates the agreement, which marks a pivotal moment for both organizations in their commitment to innovative agricultural practices, will result in between $2.5 million and $3 million in revenue over the next three years. Eko2o specializes in providing state-of-the-art…

Continue Reading

FridayDec 08, 2023 10:55 am

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Update on FDA Application for Investigational Drug

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is planning to submit an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) in the next 45 days. The application is for the company’s planned U.S. phase 1b Hypertension Clinical Trial. The filing had been delayed for necessary documentation from a raw material supplier, which is now being provided, enabling Lexaria to finalize the IND application. According to the announcement, the supplier anticipates providing the final two pieces of outstanding information to the FDA within the next 45 days, after which Lexaria can proceed…

Continue Reading

MondayAug 15, 2022 11:55 am

CBDNewsBreaks – LFTD Partners Inc. (LIFD) Releases Q2 2022 Financial Report

LFTD Partners (OTCQB: LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, is reporting on its second quarter 2022, which is the period ended June 30, 2022. Highlights of the report include revenue for the quarter totaling $16,776,502, a 151% increase from the $6,695,144 reported in Q2 2021, and an increase in operating margin of 3.14%, with Q2 2022 coming in at 26.40%. GAAP net income from the quarter increased — the eighth consecutive quarter of upward movement — totaling $3,219,460 up from $1,596,154 the same period last year. The company reported a 64% increase in basic…

Continue Reading

ThursdayMay 19, 2022 2:38 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Aims to Deliver Safer Alternative for Nicotine Experience

Lexaria Bioscience Corp. (NASDAQ: LEXX) will soon begin a human clinical study, NIC-H22-1, to compare its DehydraTECH-nicotine pouch performance with that of existing brands such as ON! and Zyn, currently available in the U.S. “Animal testing has already demonstrated that DehydraTECH-nicotine can deliver peak nicotine performance to the bloodstream 10 to 20 times faster than the study’s controls,” a recent article reads. “Lexaria has long held that any form of inhaling chemical substances can be detrimental to health, and its DehydraTECH-nicotine aims to help vapers as well as smokers wean themselves off of those products, giving them relief from cravings…

Continue Reading

TuesdayJan 25, 2022 2:28 pm

CBDNewsBreaks – Vantage Hemp Co. is in the Final Stages of its DMF Submissions

The usage of CBD as an active pharmaceutical ingredient is creating an overwhelming need for CBD manufacturers to identify their processes used in the manufacturing, packaging, and storing of pharmaceutical drug ingredients. On their way to set the industry bar, Colorado-based CBD manufacturer, Vantage Hemp Co., announces the company is in its final stages of its Drug Master File submissions to the US Food & Drug Administration. As one of the first CBD companies to file DMFs for all of its ingredients, Vantage is providing the FDA with confidential and detailed information about the quality and safety of its products. These submissions can…

Continue Reading